KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Change in Accured Expenses (2016 - 2025)

Astrana Health's Change in Accured Expenses history spans 16 years, with the latest figure at $8000.0 for Q1 2025.

  • For Q1 2025, Change in Accured Expenses fell 99.12% year-over-year to $8000.0; the TTM value through Mar 2025 reached -$31.8 million, down 705.79%, while the annual FY2024 figure was -$30.9 million, 18087.65% down from the prior year.
  • Change in Accured Expenses for Q1 2025 was $8000.0 at Astrana Health, up from -$56.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $24.8 million in Q2 2024 and bottomed at -$56.8 million in Q4 2024.
  • The 5-year median for Change in Accured Expenses is $905000.0 (2024), against an average of -$1.6 million.
  • The largest YoY upside for Change in Accured Expenses was 1398.06% in 2024 against a maximum downside of 6083.67% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$11.1 million in 2021, then surged by 92.7% to -$814000.0 in 2022, then soared by 216.58% to $949000.0 in 2023, then tumbled by 6083.67% to -$56.8 million in 2024, then soared by 100.01% to $8000.0 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Change in Accured Expenses are $8000.0 (Q1 2025), -$56.8 million (Q4 2024), and $198000.0 (Q3 2024).